← Open Payments lookup

KAITLYN JONES: Open Payments

NPI 1285231720 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,262 in 109 payments from 22 companies in 2025. Trend: 2023 $2,415 · 2024 $2,368 · 2025 $2,262

Food & beverage: $2,262
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP20$403
Amgen Inc.15$225
GlaxoSmithKline, LLC.11$215
Boehringer Ingelheim Pharmaceuticals, Inc.9$203
GENZYME CORPORATION8$186
Takeda Pharmaceuticals U.S.A., Inc.8$177
Mallinckrodt Hospital Products Inc.5$113
Vifor Pharma, Inc.5$110
Grifols USA, LLC4$90
Viatris Specialty LLC3$73

Products named: TEZSPIRE, DUPIXENT, GLASSIA, OFEV, TRELEGY ELLIPTA, ACTHAR, FASENRA, Zemaira.

Industry payments across AL — which companies pay providers there.